LEADER 00969nam0-22003131--450-
001 990008031760403321
005 20060726153558.0
035   $a000803176
035   $aFED01000803176
035   $a(Aleph)000803176FED01
035   $a000803176
100   $a20050329d1987----km-y0itay50------ba
101 0 $aita$agrc$alat
102   $aIT
105   $aa---a---001yy
200 1 $aRegio 3.$eRegium Iulium, Locri, Taurianum, Trapeia, Vibo Valentia, Copia-Thurii, Blanda Iulia$fintroduzione, edizione e commento a cura di Marco Buonocore
210   $aBari$cEdipuglia$d1987
215   $aXXV, 73 p.$cill.$d22 cm
225 1 $aInscriptiones Christianae Italiae$v5
676   $a471$v20$zita
676   $a340.5$v11 rid.$zita
702  1$aBuonocore,$bMarco
801  0$aIT$bUNINA$gRICA$2UNIMARC
901   $aBK
912   $a990008031760403321
952   $aDDR-Ep. IIa 190 (5)$b1601 ddr$fDDR$m21-5305
959   $aDDR
996   $aRegio 3$9755214
997   $aUNINA

LEADER 01312nam  2200361Ia 450 
001 9910698829503321
005 20090527141238.0
035   $a(CKB)5470000002397573
035   $a(OCoLC)352906012
035   $a(EXLCZ)995470000002397573
100   $a20090527d2002      ua             0
101 0 $aeng
135   $auran|||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 00$aGuidance for industry$b[electronic resource] $eproviding regulatory submissions to CBER in electronic format, investigational new drug applications (INDs)
210  1$aRockville, MD :$cU.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Biologics Evaluation and Research,$d[2002]
215   $ai, 22 pages $cdigital, PDF file
300   $aTitle from PDF title page (viewed on May 27, 2009).
300   $a"March 2002".
517   $aGuidance for industry 
606   $aElectronic filing systems$zUnited States
606   $aDrugs$zUnited States$xTesting
615  0$aElectronic filing systems
615  0$aDrugs$xTesting.
712 02$aCenter for Biologics Evaluation and Research (U.S.)
801  0$bGPO
801  1$bGPO
906   $aBOOK
912   $a9910698829503321
996   $aGuidance for industry$93434577
997   $aUNINA